The American College of Clinical Pharmacy's Nephrology PRN is a collegial network of pharmacists that practice in acute and chronic care of kidney disease
Joined October 2016
- Tweets166
- Following142
- Followers182
- Likes103
ACCPNephroPRN retweeted
International consensus on post-transplantation diabetes mellitus
🔓doi.org/10.1093/ndt/gfad258
ACCPNephroPRN retweeted
We are excited to share that the KDIGO Blood Pressure in CKD Guideline is now digitally available for FREE in Acumen Epic Connect via @AvoMD, allowing you to save time and standardize evidence-based care! Get started by reaching out to [email protected].
#Nephrology #CKD #BP #ClinicalDecisionSupport #EPIC #KDIGO #AvoMD
We are excited to share that we have added five new modules to our curriculum!
Register today at: kidneymedicationmanagement.n…
ACCPNephroPRN retweeted
Check out the May issue of KDIGO Direct for the latest news and updates from KDIGO: kdigo.co/KDIGO-Direct-May-20….
In this issue: International Consensus Statement on Standardized Blood Pressure Measurement, the KDIGO Home Dialysis Controversies Conference Report, the 2023 ANCA Guideline for public review, upcoming webinars, new resources, and more.
#BP #bloodpressure #ANCA #AAV #CKD #genetics #genomics #homedialysis #dialysis #glomerular
ACCPNephroPRN retweeted
📣 Join us tomorrow for our monthly journal club by some awesome PGY-2 Pharmacotherapy and Internal Medicine Residents! Zoom link can be found in your email #AMEDPRN @HFHPharmRes @RxCutshall @candradhubbard @MUHPharmRes @dukerxresidency
ACCPNephroPRN retweeted
Our new curriculum is LIVE. 🎉 If you want to learn more about Slowing Kidney Disease Progression, enroll at the link in our bio.
#TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #PharmacyUMN #GetTheMedicationRight #nephrologist #nephrologynurse #nursepractitioner
ACCPNephroPRN retweeted
KDIGO is pleased to announce the publication of the Home Dialysis Controversies Conference Report in the May 2023 issue of @Kidney_Int. The conference was co-chaired by @PD_Perls and @wilkiemart.
Read the news release: kdigo.co/Home-Dialysis-Confe…
Download the conference report: kdigo.co/Home-Dialysis-Contr…
ACCPNephroPRN retweeted
🗓 SAVE THE DATE! We are partnering with @ACCPNephro to co-host a webinar, Removing Race from the eGFR Calculation. Presented by @WendyStPeter002 and moderated by @JayCdoesID on April 19th via Zoom. Register here: bit.ly/3zA4x3v
@RenaGosser @rx_phan
ACCPNephroPRN retweeted
The magic of evolving in #criticalcare is appreciating where your patient is on the curve and determining what that means, add add add, hold up, or put Humpty Dumpty back together.
Being mindful of the creatinine blind period is as important in deterioration as recovery!
Patients with AKI experience multiple pharmacokinetic and pharmacodynamic perturbations that dynamically influence medication effectiveness and safety. This article discusses optimal medication management for patients with AKI bit.ly/CJASN0101
@AFlanneryPharmD
ALT Impact of dynamic AKI course on medication dosing in the critically ill.
Includes a nice review of clinical trials too!
And of course, #pharmacists can play 🔑 roles in supporting #adherence (*cough*pseudoresistance*cough* 😉) and best medication use practices!
🚨NEW Review:
Resistant hypertension in dialysis
📖bit.ly/3mPvJYG
📸Proposed work-up of dialysed patients with apparent treatment-resistant hypertension
ACCPNephroPRN retweeted
Meet the team that’s accelerating the implementation of comprehensive medication management services for those with kidney disease in the U.S.
#TwitteRX #pharmacists #AKHOMM #NephTwitter
ACCPNephroPRN retweeted
KDIGO is pleased to announce the formal launch of an update to its 2012 Acute Kidney Injury (#AKI) Guideline. Matthew James (Canada) and @MarliesOsterman (United Kingdom) will co-chair the guideline update.
Read the full News Release: kdigo.co/AKI-Guideline-Updat…
ACCPNephroPRN retweeted
Vancomycin 5–7.5 mg/kg q12h is recommended as the initial dosage regimens for ICU patients undergoing CRRT. buff.ly/3RPL2MD @accpinfdprn
ACCPNephroPRN retweeted
These accurate models could assist clinicians in predicting tacrolimus efficacy in pediatric patients with nephrotic syndrome before utilization to avoid treatment failure or adverse effects. buff.ly/3IeoJO3 @accppediprn @ACCPNephro
ACCPNephroPRN retweeted
Dose optimization utilizing TDM early in cefepime treatment may minimize adverse effects and improve patient safety. buff.ly/3UZBuzq @Veena_PharmD @accpinfdprn @ACCPNephro
#TwitteRx -- what are YOU wanting to 👀 in future @ACCP #NephPRN CE sessions?
Tell us in a 1-minute, one question survey! 👇
uwyo.sjc1.qualtrics.com/jfe/…
ACCPNephroPRN retweeted
KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline.
Read the Guideline:
kdigo.co/2022-Diabetes-in-CK…
Read the Executive Summary:
kdigo.co/2022-Diabetes-Guide…
Read the News Release:
kdigo.co/News-Release-2022-D…
#diabetes #CKD
